The TSX Venture Exchange has accepted for filing Imperial Ginseng Product Ltd.'s (now One Bullion Ltd.) reverse takeover (RTO), as principally described in the company's filing statement dated Oct. 10, 2025.

The RTO includes the following matters, all of which have been accepted by the exchange.

Reverse takeover -- completed

Pursuant to a merger agreement dated Sept. 11, 2024, as amended, among the company and 1001446331 Ontario Inc. (formerly One Bullion Ltd.) (OBL), a company incorporated under the laws of the Province of Ontario, the company has acquired all of the issued and outstanding OBL shares by way of a three-cornered amalgamation. In connection with the merger agreement, one postconsolidation company share was issued in exchange for every OBL share held.

Pursuant to the RTO, OBL completed a financing of 13,324,455 subscriptions receipts at a price of 36 cents per subscription receipt, for gross proceeds of $4,796,803. Each subscription receipt converts into one (postconsolidation) share and one (postconsolidation) warrant of the company on closing of the RTO. Each warrant is exercisable at a price of 48 cents for a period of 24 months, subject to an acceleration right.

For additional information, please refer to the company's filing statement dated Oct. 10, 2025, as well as the company's news releases dated April 8, 2025, May 8, 2025, Aug. 14, 2025, Oct. 8, 2025, Dec. 11, 2025, and Dec. 17, 2025, each of which are available on SEDAR+.

Private placement -- brokered

The exchange has accepted for filing documentation with respect to a brokered private placement. The private placement raised $529,399 through the issuance of 1,470,553 subscription receipts at a price of 36 cents per subscription receipt. In connection with the RTO, each subscription receipt has automatically converted into one (postconsolidation) common share and one (postconsolidation) common share purchase warrant of the company

Financing type:  brokered private placement

Gross proceeds:  $529,399.08

Offering:  1,470,553 common shares with 1,470,553 warrants (postconsolidation)

Offering price:  36 cents per postconsolidation common share

Warrant exercise terms:  48 cents per postconsolidation warrant to purchase one postconsolidation common share for a two-year period, subject to an acceleration right

Commissions in securities:  55,556 agents' warrants

Commission terms:  Each non-transferable warrant is exercisable at 36 cents for a two-year period, subject to an acceleration right.

Disclosure:  Refer to the company's news releases dated April 8, 2025, May 8, 2025, Aug. 14, 2025, Oct. 9, 2025, and Dec. 11, 2025.